Next Science Ltd ( (AU:NXS) ) has provided an announcement.
Next Science Limited has announced a change in its securityholder registry services provider from MUFG Corporate Markets (AU) Limited to Automic Pty Ltd, effective from March 17, 2025. This change allows shareholders to manage their holdings through Automic’s secure online investor portal, enhancing the efficiency and accessibility of shareholder services. This strategic move is expected to streamline operations and improve stakeholder engagement.
More about Next Science Ltd
Next Science is a medical technology company based in Sydney, Australia, with a research and development center in Florida, USA. Founded in 2012, the company focuses on developing and commercializing its proprietary XBIO™ technology, which aims to reduce biofilm-based infections in human health. The XBIO™ technology is non-toxic and effective in eradicating both biofilm-based and free-floating bacteria, and Next Science owns the patent-protected intellectual property for this technology.
YTD Price Performance: 7.14%
Average Trading Volume: 5,830
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $18.48M
Learn more about NXS stock on TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com